Domains targeting keyword myocardial infarction

CardiologySite.com was conceived as a remote learning experience for health care providers, students, residents, fellows and people interested in expanding their knowledge in specific areas of cardiology. It was designed to provide the equivalent of classroom lectures and demonstrations with the use of the latest web-based multimedia technology. To facilitate this process, lessons were designed from the ground up instead of scanning in textbooks or videotaping a slide presentation and then modifying it for use on the Internet. This site includes instructional movies, 3-D animation, panoramic views, online quiz, interactive video-clips, interactive heart sounds & murmurs and interactive echocardiograms.

Stentys offers simple, innovative solutions to international cardiologists when treating the challenging disease of their patients. When faced with a situation where choosing the appropriate stent size is not easy, such as in acute myocardial infarction or in bifurcation lesions, the STENTYS platform provides an efficient and elegant new treatment approach. The STENTYS stent can cater for a range of vessel diameters and is able to adapt itself acutely to different diameters along the vessel. It can also continue to expand over time to remain apposed to the vessel, even when there is positive remodelling.

One Minute Sometimes Means One Life

Detailed answers to the most frequently asked questions concerning heart attacks. You will be able to make better decisions concerning your own treatment.

Using Stemedica’s patented itMSCs, CardioCell explores therapies for acute myocardial infarction, chronic heart failure and peripheral artery disease.

This website provides updates of the latests news on my Research. From different angles, it focuses on processes following myocardial infarction.

Heart failure can occur at any age and has many causes; in adults it is most commonly caused by narrowings in the arteries that supply the heart muscle (coronary artery disease, or ischaemic heart disease), untreated high blood pressure or damaged heart valves.

Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.

Peer-rewieved medical journal

The Kathiresan Lab seeks to understand the genetic basis for myocardial infarction and its risk factors and to exploit these insights to prevent and treat heart disease.

Live! 4-day Course in ADVANCED ECG INTERPRETATION! / Active participation interpreting complex ECGs! / Ask questions at any time! / Small classes (just 10 to 20 participants per class) / Houston, Texas and locations around the world!

Using multimedia, HeartSite.com was designed to educate patients and their family members about the diagnosis and treatment of heart disease. On-line lecturesare also provided

Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock

A site designed to help RACP candidates with multiple choice questions, selected from the most recent NEJM, LANCET, BMJ and MJA review articles.

CMastery of coronary anatomy is helpful for most healthcare professionals because these vital blood networks can be occluded, resulting in the common medical emergency called myocardial infarction.

Learn about Non ST-segment elevation myocardial infarction including its risk factors, symptoms, diagnosis, complications, treatment, prognosis

Learn more about Activase® (Alteplase) for Acute Ischemic Stroke Treatment. Indications Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Activase is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure. Limitation of Use: The risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose AMI puts them at low risk for death or heart failure. Activase is indicated for the lysis of acute massive pulmonary embolism (PE), defined as: • Acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments. • Acute pulmonary emboli accompanied by unstable hemodynamics, e.g.,failure to maintain blood pressure without supportive measures. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Do not administer Activase to treat acute myocardial infarction or pulmonary embolism in the following situations in which the risk of bleeding is greater than the potential benefit: active internal bleeding; history of recent stroke; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Warnings and Precautions Bleeding Activase can cause significant, sometimes fatal, internal or external bleeding, especially at arterial and venous puncture sites.Avoid intramuscular injections and trauma to the patient. Fatal cases of hemorrhage associated with traumatic intubation in patients administered Activase have been reported. Heparin, aspirin, or Activase may cause bleeding complications; therefore carefully monitor for bleeding. If serious bleeding occurs, terminate the Activase infusion. Orolingual Angioedema Monitor patients during and for several hours after infusion for orolingual angioedema. If angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy. Cholesterol Embolization Cholesterol embolism, sometimes fatal, has been reported rarely in patients treated with thrombolytic agents. Reembolization of Deep Venous Thrombi during Treatment for Acute Massive Pulmonary Embolism Consider the possible risk of reembolization due to the lysis of underlying deep venous thrombi patients with acute massive PE Coagulation Tests May be Unreliable during Activase Therapy Coagulation tests and/or measures of fibrinolytic activity may be unreliable during Activase therapy. Adverse Reactions The most frequent adverse reaction associated with Activase therapy is bleeding. Allergic‑type reactions, e.g.,anaphylactoid reaction, laryngeal edema, orolingual angioedema, rash, and urticaria have been reported.

Find and save ideas about bed and shower ,to compare the perceptions of patients with acute myocardial infarction concerning bed and shower baths and evaluate how antecedent variables influence their perceptions.